Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BNGO | Bionano Genomics, Inc.

Index- P/E- EPS (ttm)-4.87 Insider Own- Shs Outstand35.35M Perf Week-9.23%
Market Cap108.74M Forward P/E- EPS next Y-3.25 Insider Trans- Shs Float35.12M Perf Month-2.64%
Income-146.50M PEG- EPS next Q-0.94 Inst Own27.30% Short Float / Ratio13.59% / 4.41 Perf Quarter-52.28%
Sales31.50M P/S3.45 EPS this Y-75.20% Inst Trans-18.93% Short Interest4.77M Perf Half Y-72.94%
Book/sh6.82 P/B0.43 EPS next Y18.50% ROA-49.10% Target Price20.20 Perf Year-85.40%
Cash/sh2.09 P/C1.41 EPS next 5Y- ROE-60.00% 52W Range2.93 - 30.10 Perf YTD-79.79%
Dividend- P/FCF- EPS past 5Y28.50% ROI-52.70% 52W High-90.20% Beta2.23
Dividend %- Quick Ratio2.70 Sales past 5Y23.90% Gross Margin25.40% 52W Low0.68% ATR0.26
Employees405 Current Ratio3.70 Sales Q/Q29.90% Oper. Margin- RSI (14)30.90 Volatility5.75% 8.24%
OptionableYes Debt/Eq0.02 EPS Q/Q-9.70% Profit Margin- Rel Volume0.32 Prev Close2.98
ShortableYes LT Debt/Eq0.02 EarningsAug 09 AMC Payout- Avg Volume1.08M Price2.95
Recom1.40 SMA20-11.82% SMA50-31.02% SMA200-70.28% Volume275,846 Change-1.01%
Date Action Analyst Rating Change Price Target Change
Jan-05-23Initiated Scotiabank Sector Outperform $4
Dec-12-22Resumed BTIG Research Buy $3.50
Jul-18-22Resumed Oppenheimer Outperform $12
Jun-16-21Initiated BTIG Research Buy $10
Sep-24-20Initiated Ladenburg Thalmann Buy $1.25
Apr-08-20Initiated Oppenheimer Outperform $1.50
Sep-21-23 12:00PM
Sep-14-23 08:00AM
Sep-11-23 04:06AM
Sep-06-23 08:00AM
07:00AM Loading…
Sep-04-23 07:00AM
Aug-30-23 08:00AM
Aug-28-23 10:22AM
Aug-21-23 04:05PM
Aug-16-23 08:00AM
Aug-14-23 06:17PM
Aug-11-23 08:00AM
Aug-10-23 06:41PM
09:11AM Loading…
Aug-09-23 08:30PM
Aug-04-23 12:00PM
Aug-02-23 08:00AM
Aug-01-23 05:30AM
Jul-31-23 08:00AM
Jul-27-23 08:00AM
Jul-05-23 06:08PM
Jun-29-23 05:09PM
Jun-26-23 05:14PM
Jun-21-23 08:41PM
08:00AM Loading…
Jun-20-23 08:00AM
Jun-15-23 06:38AM
Jun-14-23 07:19PM
Jun-13-23 08:00AM
Jun-12-23 08:00AM
Jun-08-23 08:00AM
Jun-06-23 08:00AM
May-19-23 06:40AM
May-13-23 09:24AM
May-10-23 08:13AM
May-09-23 05:25PM
May-06-23 08:00AM
May-05-23 06:08AM
May-02-23 08:00AM
May-01-23 07:50PM
Apr-26-23 08:00AM
Apr-25-23 04:55PM
Apr-24-23 03:51PM
Apr-19-23 12:35PM
Apr-13-23 04:01PM
Apr-11-23 05:21AM
Apr-07-23 06:45AM
Apr-06-23 08:00AM
Mar-22-23 08:00AM
Mar-16-23 09:57AM
Mar-15-23 08:00AM
Mar-13-23 10:40AM
Mar-10-23 09:22AM
Mar-09-23 09:30PM
Mar-07-23 09:45AM
Mar-05-23 07:20AM
Mar-02-23 09:13AM
Mar-01-23 12:49PM
Feb-28-23 10:00AM
Feb-27-23 08:00AM
Feb-22-23 08:00AM
Feb-14-23 04:39PM
Feb-13-23 09:40AM
Feb-10-23 11:01AM
Feb-09-23 04:05PM
Feb-02-23 08:00AM
Jan-26-23 09:40AM
Jan-24-23 08:00AM
Jan-23-23 08:01AM
Jan-20-23 08:00AM
Jan-18-23 09:22AM
Jan-12-23 08:00AM
Jan-11-23 08:00AM
Jan-10-23 09:40AM
Jan-06-23 08:00AM
Jan-05-23 08:00AM
Dec-30-22 11:34AM
Dec-22-22 09:50AM
Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mamuszka HannahDirectorJun 13Buy0.7665,78950,00065,789Jun 14 06:32 PM
Holmlin R. ErikPresident and CEOMay 16Buy0.6415,0009,639806,474May 16 06:23 PM
Stewart Christopher P.Chief Financial OfficerMay 12Buy0.6750,00033,415281,373May 16 06:22 PM